Showing 49 to 60 of 61 results
AI-Powered Dietary Study to Reveal Personalized Weight Management Strategies in 2025
A major US study analyzing data from over 8,000 adults will publish initial results in early 2025, utilizing AI to analyze genetic factors, gut microbiome, lifestyle, and prior illnesses to improve predictions of individual responses to diets and long-term dietary changes.
AI-Powered Dietary Study to Reveal Personalized Weight Management Strategies in 2025
A major US study analyzing data from over 8,000 adults will publish initial results in early 2025, utilizing AI to analyze genetic factors, gut microbiome, lifestyle, and prior illnesses to improve predictions of individual responses to diets and long-term dietary changes.
Progress
40% Bias Score
US Companies to Begin Clinical Trials for Pig Organ Transplants in 2025
Facing a critical organ shortage, two US companies aim to start clinical trials in 2025 using genetically modified pig organs for transplantation, offering hope to patients like Alex Berrios who need transplants but lack compatible human donors.
US Companies to Begin Clinical Trials for Pig Organ Transplants in 2025
Facing a critical organ shortage, two US companies aim to start clinical trials in 2025 using genetically modified pig organs for transplantation, offering hope to patients like Alex Berrios who need transplants but lack compatible human donors.
Progress
48% Bias Score
Boston Scientific's Use of Unclaimed Bodies Sparks Ethical Debate and Policy Changes
Boston Scientific, a major medical technology company, used at least 25 unclaimed bodies for training purposes, prompting internal debate and policy changes after an NBC News investigation revealed the practice; the company has since severed ties with the provider and updated its policies to require...
Boston Scientific's Use of Unclaimed Bodies Sparks Ethical Debate and Policy Changes
Boston Scientific, a major medical technology company, used at least 25 unclaimed bodies for training purposes, prompting internal debate and policy changes after an NBC News investigation revealed the practice; the company has since severed ties with the provider and updated its policies to require...
Progress
52% Bias Score
Gene Therapy Shows Promise in Treating Fanconi Anemia
A Spanish-led team successfully used gene therapy to treat Fanconi anemia in nine children, achieving significant improvements and offering a safer alternative to bone marrow transplants.
Gene Therapy Shows Promise in Treating Fanconi Anemia
A Spanish-led team successfully used gene therapy to treat Fanconi anemia in nine children, achieving significant improvements and offering a safer alternative to bone marrow transplants.
Progress
16% Bias Score
Six Monkeys Still Loose After South Carolina Escape
Dozens of monkeys escaped from a South Carolina primate breeding facility; six remain at large.
Six Monkeys Still Loose After South Carolina Escape
Dozens of monkeys escaped from a South Carolina primate breeding facility; six remain at large.
Progress
36% Bias Score
Blood Pressure: Systolic vs. Diastolic
This article discusses the current guidelines for blood pressure, focusing on both systolic and diastolic pressure, and the potential risks associated with excessively low diastolic pressure.
Blood Pressure: Systolic vs. Diastolic
This article discusses the current guidelines for blood pressure, focusing on both systolic and diastolic pressure, and the potential risks associated with excessively low diastolic pressure.
Progress
0% Bias Score
Record-Breaking Philanthropy in Higher Education: 2024 Mega-Gifts
In 2024, over a dozen higher education institutions received mega-gifts exceeding $100 million each, totaling over $5 billion, with medical education and research, financial aid, and minority-serving institutions as major beneficiaries.
Record-Breaking Philanthropy in Higher Education: 2024 Mega-Gifts
In 2024, over a dozen higher education institutions received mega-gifts exceeding $100 million each, totaling over $5 billion, with medical education and research, financial aid, and minority-serving institutions as major beneficiaries.
Progress
28% Bias Score
AI Blood Tests Show Promise in Early Ovarian Cancer Detection
New AI-powered blood tests are showing promise in detecting ovarian cancer five years before symptoms appear, improving diagnosis and survival rates; AI also speeds up pneumonia diagnosis and antibiotic selection, reducing costs and improving patient care.
AI Blood Tests Show Promise in Early Ovarian Cancer Detection
New AI-powered blood tests are showing promise in detecting ovarian cancer five years before symptoms appear, improving diagnosis and survival rates; AI also speeds up pneumonia diagnosis and antibiotic selection, reducing costs and improving patient care.
Progress
44% Bias Score
Parents Sell Home to Fund Gene Therapy Research for Daughter with Ultra-Rare Disease
Tallulah Moon, a toddler from Australia, was misdiagnosed with leukodystrophy but later diagnosed with the ultra-rare SPG56; her parents are spearheading a $5 million gene therapy research project to find a cure, selling their home to fund part of the endeavor.
Parents Sell Home to Fund Gene Therapy Research for Daughter with Ultra-Rare Disease
Tallulah Moon, a toddler from Australia, was misdiagnosed with leukodystrophy but later diagnosed with the ultra-rare SPG56; her parents are spearheading a $5 million gene therapy research project to find a cure, selling their home to fund part of the endeavor.
Progress
16% Bias Score
Early Puberty in Young Girls: A Growing Concern
The article discusses the increasing incidence of precocious puberty in young girls in India, highlighting the concerns of parents and the medical professionals trying to understand and address this phenomenon.
Early Puberty in Young Girls: A Growing Concern
The article discusses the increasing incidence of precocious puberty in young girls in India, highlighting the concerns of parents and the medical professionals trying to understand and address this phenomenon.
Progress
20% Bias Score
EMA Approves Alzheimer's Drug Leqembi
The European Medicines Agency approves Leqembi, a new Alzheimer's drug, with strict conditions to mitigate serious side effects.
EMA Approves Alzheimer's Drug Leqembi
The European Medicines Agency approves Leqembi, a new Alzheimer's drug, with strict conditions to mitigate serious side effects.
Progress
0% Bias Score
Gene Therapy Breakthrough for Duchenne Muscular Dystrophy
A gene therapy developed by Généthon shows remarkable success in treating Duchenne muscular dystrophy in a young boy, offering hope for future treatments. Further research is underway.
Gene Therapy Breakthrough for Duchenne Muscular Dystrophy
A gene therapy developed by Généthon shows remarkable success in treating Duchenne muscular dystrophy in a young boy, offering hope for future treatments. Further research is underway.
Progress
0% Bias Score
Showing 49 to 60 of 61 results